ArticleJournal of gastrointestinal cancer2026

Third-Line Treatment Timing After Second-Line Discontinuation in Advanced Pancreatic Cancer: A 30-Day Landmark Analysis.

Kohei Nagata et al.PubMed ↗Publisher ↗

No numbers read from the abstract.